MIRM Stock Analysis: Buy, Sell, or Hold?
MIRM - Mirum Pharmaceuticals, Inc. Common Stock
$125.59
5.13 (4.26%)
▲
5d:
+7.09%
30d:
+36.26%
90d:
+32.73%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When MIRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MIRM is 15.7% above its trading range ($108.53). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MIRM is 15.7% above its trading range ($108.53). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MIRM is currently trading at $125.59, which is considered extended relative to its 30-day fair value range of $92.87 to $108.53. From a valuation perspective, the stock is trading at a discount (Forward PE: -1435.3) compared to its historical average (185.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is approaching resistance at $125.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: MIRM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $145.36 (+15.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is approaching resistance at $125.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: MIRM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $145.36 (+15.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$92.87 -
$108.53
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
MIRM is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading below Wall St target ($145.36)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to 15.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$92.87 -
$108.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$104.35
Resistance Level
$125.50
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1435.31
Wall Street Target
$145.36
(+15.7%)
Revenue Growth (YoY)
43.3%
Profit Margin
-140.2%
PE vs Historical
-1435.3 vs 185.2
CHEAP
Share & Embed Analysis
Last updated: July 02, 2026 9:40 PM ET
Data refreshes hourly during market hours. Next update: 10:40 PM
Data refreshes hourly during market hours. Next update: 10:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Bjerkholt
SELL
7287 shares
2026-03-16
Joanne Quan
SELL
7287 shares
2026-03-16
Jolanda Howe
SELL
4732 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
Advanced MIRM Option Strategies
Professional options setups generated by AI based on today's MIRM price and gamma walls.
